An inadequately disinfected instrument put 89 patients at the Sept-Îles hospital at a “low to moderate” risk of contracting HIV or hepatitis B and C.
The CISSS de la Côte-Nord asks people who underwent a prostate biopsy between November 7, 2018 and March 7, 2022 to submit to a blood test. The organization has sent a letter to the patients concerned “over the past few days”, writes the CISSS in a press release.
“We know that the announcement of this potential risk of infection [sic], although low to moderate, may cause concern among those concerned, wrote in a press release Nathalie Tremblay, risk manager at the CISSS. We sincerely regret any inconvenience this may cause. »
It is an analysis of the Center of expertise in the reprocessing of medical devices (CERDM) which estimates the danger of contamination “low to moderate”. Screening is requested “as a preventive measure”, specifies the press release issued by the CISSS on Tuesday morning.
The Sept-Îles hospital center completely revised its disinfection procedure as soon as the problem became known, assures the CISSS. “As of March 7, 2022, the required measures have been put in place to correct the situation,” the statement said. Among these: the purchase of additional biopsy devices which makes it possible to “meet the needs of medical personnel and ensure disinfection according to the standards in force. »
More details to come.
To see in video